MX361222B - Composiciones sellantes. - Google Patents
Composiciones sellantes.Info
- Publication number
- MX361222B MX361222B MX2015007625A MX2015007625A MX361222B MX 361222 B MX361222 B MX 361222B MX 2015007625 A MX2015007625 A MX 2015007625A MX 2015007625 A MX2015007625 A MX 2015007625A MX 361222 B MX361222 B MX 361222B
- Authority
- MX
- Mexico
- Prior art keywords
- sealant
- compositions
- sealant compositions
- combination
- well
- Prior art date
Links
- 239000000565 sealant Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 4
- 108010049003 Fibrinogen Proteins 0.000 abstract 1
- 102000008946 Fibrinogen Human genes 0.000 abstract 1
- 208000032843 Hemorrhage Diseases 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 108010000499 Thromboplastin Proteins 0.000 abstract 1
- 102000002262 Thromboplastin Human genes 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940012952 fibrinogen Drugs 0.000 abstract 1
- 230000002439 hemostatic effect Effects 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/10—Polypeptides; Proteins
- A61L24/106—Fibrin; Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
- A61L33/06—Use of macromolecular materials
- A61L33/12—Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
- A61L33/126—Fibrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Surgery (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Sealing Material Composition (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12198839.8A EP2745852A1 (en) | 2012-12-21 | 2012-12-21 | Sealant compositions |
| PCT/EP2013/077674 WO2014096354A1 (en) | 2012-12-21 | 2013-12-20 | Sealant compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015007625A MX2015007625A (es) | 2015-12-15 |
| MX361222B true MX361222B (es) | 2018-11-30 |
Family
ID=47563088
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015007625A MX361222B (es) | 2012-12-21 | 2013-12-20 | Composiciones sellantes. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20160082145A1 (enExample) |
| EP (2) | EP2745852A1 (enExample) |
| JP (1) | JP6518591B2 (enExample) |
| CN (1) | CN104955493A (enExample) |
| AU (1) | AU2013366544B2 (enExample) |
| BR (1) | BR112015014926B1 (enExample) |
| CY (1) | CY1118938T1 (enExample) |
| DK (1) | DK2934612T3 (enExample) |
| ES (1) | ES2627053T3 (enExample) |
| HR (1) | HRP20170880T1 (enExample) |
| HU (1) | HUE034649T2 (enExample) |
| LT (1) | LT2934612T (enExample) |
| MX (1) | MX361222B (enExample) |
| PL (1) | PL2934612T3 (enExample) |
| PT (1) | PT2934612T (enExample) |
| SI (1) | SI2934612T1 (enExample) |
| WO (1) | WO2014096354A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109010906B (zh) * | 2018-08-16 | 2021-05-14 | 陈明远 | 一种促进术后伤口局部止血及促进术后创面上皮化的生物胶水及其工作方法 |
| US11666682B2 (en) * | 2020-08-31 | 2023-06-06 | Ethicon, Inc. | Method of stopping CSF leaks and apparatus therefor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3591837B2 (ja) * | 1994-02-17 | 2004-11-24 | ニューヨーク・ブラッド・センター・インコーポレイテッド | フィブリン膠およびリポソームを含有する生物学的生体接着剤組成物、その製造方法および使用 |
| WO1997029792A1 (en) * | 1996-02-20 | 1997-08-21 | Cohesion Corporation | Tissue sealant compositions and methods of use thereof |
| WO1999018931A1 (en) * | 1997-10-10 | 1999-04-22 | University Of Virginia | Use of fibrin sealant to maintain hemostasis, lymphostasis and prevent local accumulation of body fluids |
| EP1749536A1 (en) * | 2005-08-03 | 2007-02-07 | Thrombotargets Europe, S.L. | Activated factor X stimulants as new antihemorrhagic agents for topical use |
| EP1939218A1 (en) * | 2006-12-29 | 2008-07-02 | Thrombotargets Europe, S.L. | Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| EP2145695A1 (de) | 2008-07-14 | 2010-01-20 | Sika Technology AG | Vorrichtung zur Klebstoffapplikation |
| EP2380905A1 (en) | 2010-04-19 | 2011-10-26 | Thrombotargets Europe, S.L. | Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof |
-
2012
- 2012-12-21 EP EP12198839.8A patent/EP2745852A1/en not_active Withdrawn
-
2013
- 2013-12-20 MX MX2015007625A patent/MX361222B/es active IP Right Grant
- 2013-12-20 BR BR112015014926A patent/BR112015014926B1/pt not_active IP Right Cessation
- 2013-12-20 US US14/653,862 patent/US20160082145A1/en not_active Abandoned
- 2013-12-20 CN CN201380071345.XA patent/CN104955493A/zh active Pending
- 2013-12-20 SI SI201330670T patent/SI2934612T1/sl unknown
- 2013-12-20 ES ES13821692.4T patent/ES2627053T3/es active Active
- 2013-12-20 WO PCT/EP2013/077674 patent/WO2014096354A1/en not_active Ceased
- 2013-12-20 DK DK13821692.4T patent/DK2934612T3/en active
- 2013-12-20 PL PL13821692T patent/PL2934612T3/pl unknown
- 2013-12-20 EP EP13821692.4A patent/EP2934612B1/en active Active
- 2013-12-20 AU AU2013366544A patent/AU2013366544B2/en not_active Ceased
- 2013-12-20 HU HUE13821692A patent/HUE034649T2/hu unknown
- 2013-12-20 LT LTEP13821692.4T patent/LT2934612T/lt unknown
- 2013-12-20 PT PT138216924T patent/PT2934612T/pt unknown
- 2013-12-20 HR HRP20170880TT patent/HRP20170880T1/hr unknown
- 2013-12-20 JP JP2015548630A patent/JP6518591B2/ja not_active Expired - Fee Related
-
2017
- 2017-06-08 CY CY20171100597T patent/CY1118938T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2934612T1 (sl) | 2017-08-31 |
| CN104955493A (zh) | 2015-09-30 |
| DK2934612T3 (en) | 2017-06-26 |
| PT2934612T (pt) | 2017-06-26 |
| CY1118938T1 (el) | 2018-01-10 |
| AU2013366544B2 (en) | 2017-05-25 |
| JP6518591B2 (ja) | 2019-05-22 |
| ES2627053T3 (es) | 2017-07-26 |
| HRP20170880T1 (hr) | 2017-08-25 |
| LT2934612T (lt) | 2017-07-25 |
| BR112015014926B1 (pt) | 2020-01-28 |
| WO2014096354A1 (en) | 2014-06-26 |
| EP2934612A1 (en) | 2015-10-28 |
| EP2745852A1 (en) | 2014-06-25 |
| MX2015007625A (es) | 2015-12-15 |
| JP2016510315A (ja) | 2016-04-07 |
| US20160082145A1 (en) | 2016-03-24 |
| HUE034649T2 (hu) | 2018-02-28 |
| EP2934612B1 (en) | 2017-03-15 |
| AU2013366544A1 (en) | 2015-07-09 |
| PL2934612T3 (pl) | 2017-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013061309A3 (en) | New a-prp medical device & tissue engineering composition, manufacturing machines and process | |
| MX2012007922A (es) | Sellante de fibrina en polvo seco. | |
| MX384253B (es) | Composiciones y metodos que comprenden una variante de enzima lipolitica | |
| MX337248B (es) | Variantes de plasminogeno y plasmina. | |
| MX361862B (es) | Composiciones y métodos que comprenden variante de enzima lipolítica. | |
| PH12013500467A1 (en) | Pharmaceutical composition | |
| EP2547355A4 (en) | TFPI INHIBITORS AND METHODS OF USE THEREOF | |
| MX347808B (es) | Variantes de plasminogeno y plasmina. | |
| MX345259B (es) | Inhibidores de serina proteasas similares a tripsina, y su preparación y uso. | |
| EP4414376A3 (en) | Novel depsipeptide and uses thereof | |
| MX2015012107A (es) | Barras limpiadoras que comprenden copolímeros anfifílicos superhidrófilos y métodos de uso de estas. | |
| MX356755B (es) | Compuestos de tipo fumagilol y metodos para su elaboración y uso. | |
| PH12014501176A1 (en) | Anticoagulant reversal agents | |
| PH12015501302A1 (en) | Compositions comprising vortioxetine and donepezil | |
| UA118670C2 (uk) | Способи та композиції для загоєння ран | |
| MX367393B (es) | Composiciones antifungicas para el tratamiento de piel y uñas. | |
| GB201213484D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods of using the same | |
| EP2655399A4 (en) | TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, THEIR SYNTHESIS AND THEIR USE AS SELECTIVE INHIBITORS OF COAGULATION IIA AND XA FACTORS | |
| NZ717930A (en) | Compositions for the treatment of hypertension and/or fibrosis | |
| MX2011009277A (es) | Composicion de leucocito activada. | |
| MX2015009348A (es) | Composiciones hemostaticas. | |
| MY173548A (en) | Fxa variant compositions | |
| MX2015007625A (es) | Composiciones sellantes. | |
| MX2015001648A (es) | Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos. | |
| EA201491455A1 (ru) | ЭФФЕКТОРЫ β-АРРЕСТИНА, КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ, И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |